Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
Seera Holding Group prints its August 24 results with board members sitting on paper gains from a multi-month buying campaign — the question now is whether the numbers validate that conviction. The insider buying…
Zhejiang Supor enters its August 28 earnings release with insiders selling and the stock down 8% over the past month — a setup that puts the upcoming print under sharper focus than usual. The insider angle is the most…
XMA, the iShares S&P/TSX Capped Materials Index ETF, has become one of the stronger performers on the TSX this month — up nearly 29% over 30 days and 11.6% in the past week alone, closing at CAD 50.99. The price action…
Lucky Cement Limited enters the final stretch of August as a relative outlier in a sector that has broadly weakened — down just 1.4% on the week while most of its closest peers lost considerably more ground. The peer…
Alfresa Holdings heads into the final stretch of August with its lending market tightening meaningfully — borrow demand has roughly doubled since early July, even as the stock quietly extends a modest weekly gain. The…
ENRD has entered a new phase of bearish pressure this week — short interest has more than quadrupled since Monday while the lending market has tightened to its most extreme point in the recent record. The scale of the…
Infleqtion enters the post-earnings week with shorts in full retreat, calls still dominant, and the borrow market stubbornly locked — a setup that has visibly rewarded bulls over the past month. The clearest shift…
Beta Bionics heads into the back half of August with a striking contradiction at its core: short sellers are adding positions at their fastest rate in months, yet options traders are the most bullish they have been all…
Oruka Therapeutics heads into the back half of August with a striking split: short sellers have been quietly unwinding positions for a month while insiders cashed out in size last week. The most notable development…
Nuvectis Pharma enters the final week of August with a striking disconnect at its core: the stock has rallied 24% in a single week and is up more than 200% year-to-date, yet short interest remains elevated at nearly 7%…
Cytek Biosciences heads into the final stretch of August with short sellers quietly retreating, the borrow market extraordinarily relaxed, and the next earnings date already fixed for November — leaving the stock to…
Texas Pacific Land Corporation extended its post-earnings recovery this week, gaining 7% to close at $383.64 — yet the short base that absorbed the August selloff remains almost entirely intact, setting up a quiet but…
The Real Brokerage Inc. heads into the weekend with its two loudest signals pointing in opposite directions — options traders turning sharply more optimistic while short sellers, sitting on 14.3% of the free float,…
Royalty Pharma enters the final stretch of August with an awkward split: options positioning remains at its most call-heavy reading of the past year while the executives running the company have been selling into the…
SGOV enters the back half of August with an unusual split: short sellers are quietly cutting exposure while options traders are growing more defensive than they have been in months. The most interesting development…
Onto Innovation spent the week down 11.6% to $293.33 — one of the steeper drops among its semiconductor equipment peers — arriving just days after Goldman Sachs initiated coverage with a Buy and a $400 target, making…
Entera Bio has become one of the more striking small-cap biotech setups of the summer — a stock up 65% in a month while short sellers pile in at a pace not seen in years. The lending market tells the most urgent story…
TWLO enters the back half of August with a striking split in its story: a post-earnings stock that rallied nearly 25% in a single day is now giving back ground, while almost every analyst who covers it just raised…
HUBB heads into the back half of August carrying an 8% weekly loss and options positioning that has turned unusually protective — a combination that makes this week's setup worth examining closely. The clearest signal…
UBS Group AG enters the final stretch of August on the back foot, down 2.4% on the week to CHF 42.50, with the next earnings catalyst still two months away and the stock giving back some of its strong run from the…
